Office of Research COVID-19 Extramural Research Funding - Office of Research

COVID-19 Extramural Research Funding

Return to COVID-19 Research Working Group website

COVID-19 research funding opportunities relevant to UC Davis researchers will be added to this table as they are released by federal and state funding agencies, foundations, non-profits and industry partners. Please use the sorting and search tools below to find the opportunities most useful to you. Suggest additional entries by emailing msparling@ucdavis.edu.

The Office of Foundation and Corporate Engagement provides support for your proposals to foundations and corporate sponsors (fce@ucdavis.edu). All proposals for sponsored projects funded by government or non-profit sponsors are reviewed and authorized for submission by the Sponsored Programs Office (SPO). SPO is currently offering an expedited review process for all COVID-19 related proposals. Contact them at proposals@ucdavis.edu.

SponsorSponsor TypeProgram TitleLinkSponsor DeadlinePosted OnFunding Area(s)DescriptionAmount
National Institutes of Health (NIH-NIAID)NIHEmergency Awards: Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed)https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-050.html10/22/202107/16/2021Epidemiology / Public Health; Life SciencesThis Funding Opportunity Announcement (FOA) solicits applications from single institutions or consortia of institutions to participate in the Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern program. The purpose of this program is to support comprehensive multidisciplinary research Centers focused on innovative antiviral drug development targeting coronaviruses (CoVs), emphasizing SARS-CoV-2, and one or more select RNA viruses with pandemic potential. NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for the 2019 Novel Coronavirus (COVID-19), and within the provisions described in the "American Rescue Plan Act of 2021."Application budgets are limited to $15 million for FY2022 direct costs per year and need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum period is 5 years.
National Institutes of Health (NIH-NICHD)NIHNotice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilitieshttps://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-038.html09/08/2021 first due date07/08/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis NOSI encourages applications that address dimensions of access, acceptance and uptake of CDC-recommended vaccines among infants, children, adolescents, pregnant and lactating women, and persons with disabilities, especially among populations who are underserved or experience health disparities.
US Small Business Administration (SBA)Non-NIH FederalCommunity Navigator Pilot Programhttps://ucdavis.infoready4.com/#competitionDetail/184645707/23/2021* Limited Submission06/30/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis is a limited submission opportunity. UC Davis may only submit 1 application as an organization. Please click the link provided to be taken to the campus competition page. Questions? Contact limbsubmissions@ucdavis.edu Up to $5M
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collidehttps://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-057.html09/07/2021 first deadline06/29/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Notice of Special Interest (NOSI) is to communicate special interest in epidemiology investigations to quantify the impact of the coronavirus disease 2019 (COVID-19) pandemic on Human Immunodeficiency Virus (HIV) prevention, incidence, transmission, and outcomes. This NOSI encourages research on the impact and strategies needed to adapt the HIV/AIDS response through agile and innovative support of prevention and care and the maintenance of sustained HIV viral suppression during the coronavirus disease 2019 (COVID-19) pandemic.
Department of LaborNon-NIH FederalWorkplace Safety and Health Training on Infectious Diseases, Including COVID-19https://ucdavis.infoready4.com/#competitionDetail/184642807/26/2021* Limited Submission06/29/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis is a limited submission opportunity. UC Davis may only submit 1 application as an organization. Please click the link provided to be taken to the campus competition page. Questions? Contact limbsubmissions@ucdavis.edu
Centers for Disease Control (CDC)Non-NIH FederalEmerging Infections Sentinel Networks (EISN) Research - FORECASThttps://www.grants.gov/web/grants/view-opportunity.html?oppId=33447210/19/2021 Estimated06/29/2021Epidemiology / Public Health; Life SciencesThe purpose of this Notice of Funding Opportunity (NOFO) is to provide a funding mechanism for Emerging Infections Sentinel Networks (EISN) research activities, specifically within a network of emergency departments (EDs). The EISN program will assist in operating emergency department provider-based sentinel networks. These networks will contribute to surveillance for emerging infectious diseases (EID), such as those caused by agents of bioterrorism, pathogens of pandemic potential, drug-resistant, foodborne or waterborne microorganisms, and vaccine-preventable or potentially vaccine-preventable diseases (e.g., Bacillus anthracis. new coronaviruses, Clostridium difficile, carbapenem-resistant Enterobacteriaceae, viral hepatitis and respiratory viruses of epidemic or pandemic potential, tuberculosis, sexually transmitted diseases), and help inform operational public health and healthcare decisions during public health emergencies (e.g., assessment of rapid screening and triage protocols during surge of infectious disease cases presenting for clinical care; assessment of clinical characteristics and development of rapid epidemiologic studies during emergencies to improve the understanding of the clinical characteristics, impacts and outcomes of new and emerging diseases), help better understand and address the disproportionate impact of EIDs on underserved and disadvantaged populations, and enhance information exchange.
National Institutes of Health (NIH-NIAID)NIHNotice of Intent to Publish a Funding Opportunity Announcement for Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19)https://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-064.html10/15/2021 estimated06/18/2021Epidemiology / Public Health; Life SciencesThe National Institute of Allergy and Infectious Diseases (NIAID) intends to publish a Funding Opportunity Announcement (FOA) to solicit applications to establish Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern. This multidisciplinary research program will focus on advancing discovery and development of new or improved antivirals targeting coronaviruses, with an emphasis on SARS-CoV-2, and one or more viral pathogens from the following RNA virus families of pandemic potential: Paramyxoviruses; Bunyaviruses (Bunyavirales); Togaviruses; Filoviruses; Picornaviruses; or Flaviviruses.NIAID intends to cap direct costs at $15 million
Pfizer Inc.Industry SponsorCOVID-19 Impact and SARS-CoV-2 Viral Lifecyclehttps://www.pfizer.com/purpose/independent-grants/competitive-grants07/08/202106/16/2021Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Jody Dahms (jadahms@ucdavis.edu), Director of Corporate Engagement
US Food and Drug Administration (FDA)Non-NIH FederalInnovation Grant: COVID-19 and Health Equity (R01) - FORECASTEDhttps://www.grants.gov/web/grants/view-opportunity.html?oppId=33412603/31/2022 estimated06/16/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this funding opportunity announcement (FOA) is to fund COVID research that will strengthen and advance research in minority health and healthy equity, increase understanding of health disparities, and provide future direction for research that will contribute to regulatory decision making.Floor $50,000; Ceiling $1,000,000
Centers for Disease Control (CDC)Non-NIH FederalEnhancing Global Health Security: Strengthening Public Health Surveillance Systems and Preparedness Globallyhttps://www.grants.gov/web/grants/view-opportunity.html?oppId=32941008/09/202106/11/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborActivities under this Notice of Funding Opportunity (NOFO) should focus on protecting and improving public health globally by: 1) strengthening public health surveillance systems; 2) improving the public health surveillance workforce; 3) improving the interface between public health disease surveillance and laboratory systems; 4) reinforcing emergency surveillance preparedness; 5) enhancing electronic disease surveillance platforms and systems; and 6) enhancing the use of surveillance data for public health action. This NOFO is intended to support global health security partners to develop or continue the implementation of surveillance activities that focus on protecting and improving public health globally through strategic planning, policy, strengthening surveillance capacities and systems through partnerships. These should build and improve regional and country capacities to prevent, detect, respond and control infectious disease outbreaks, strengthen border health security and mitigate public health events of international concern (PHEICs) or other global health threats.
National Institutes of Health (NIH)NIHShared Personal Protective Equipment (PPE) Resources (S10)https://grants.nih.gov/grants/guide/pa-files/PAR-21-257.html09/24/2021 first deadline06/11/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe National Institutes of Health (NIH) hereby notifies the applicant community that funds may be available to provide Personal Protective Equipment (PPE) to directly support the needs of the NIH Clinical Trials and Clinical Research Activities.
US Department of Agriculture (USDA)Non-NIH FederalNational Animal Disease Preparedness and Response Program 2021https://www.grants.gov/web/grants/view-opportunity.html?oppId=33403408/06/202106/11/2021Epidemiology / Public Health; Life SciencesThrough the NADPRP program, APHIS provides funds to support high-value projects that will help prevent the introduction and spread of foreign and emerging animal diseases that threaten U.S. agriculture. Each year, APHIS makes funding available to support projects in priority areas of animal disease preparedness and response that are identified through consultation with eligible entities and stakeholders. Additional details about the program are available on the USDA APHIS NADPRP website.
US Department of State (DOS - Office of the Secretary)Non-NIH FederalCOVID-19 Private Sector Engagement & Partnership Fundhttps://www.grants.gov/web/grants/view-opportunity.html?oppId=33373208/27/202105/24/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThrough this APS, the Department of State (DOS) announces its desire to engage private sector partners to expand and amplify the Department’s COVID-19 response. The Fund seeks to support private sector interventions and build upon private sector investments in response to the virus.Anticipated award amount range is $50,000 to $1,000,000, however, concept papers over this amount will be considered; performance period 12 to 36 months
National Institutes of Health (NIH-NIMH, NIDA)NIHNotice of Special Interest (NOSI): Research on Strategies to Enhance Mental Health Interventions and Services within Employment and Job Training Settingshttps://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-230.html09/08/2023 expiration date05/11/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Notice of Special Interest (NOSI) is to encourage research focused on detection and intervention to prevent or treat mental health concerns, symptoms or disorders including drug-related conditions among unemployed and underemployed people participating in employment programs and job training settings (referred to here as “employment service customers” or “customers”). Considering the COVID-19 pandemic, the sharp rise and potentially long duration of unemployment raises concerns about the development and worsening of mental health symptoms and disorders, drug use behaviors, and suicide risk and necessitates further research to confirm the efficacy or demonstrate effectiveness of strategies in this area.
US Food and Drug Administration (FDA)Non-NIH FederalPediatric and Perinatal COVID-19 Registry (U18) Clinical Trials Optionalhttps://grants.nih.gov/grants/guide/rfa-files/RFA-FD-21-035.html07/06/202105/04/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe goal of this program is to support the development of a compendium-type resource incorporating pediatric and perinatal COVID-19 registries, natural history, and other data to support the linkage of mother-infant pair data in COVID-19 positive mothers and to identify the short and longer-term outcomes in neonates and infants who are perinatally exposed to and/or test positive for SARS CoV-2.It is anticipated that up to one award will be made, not to exceed $1,000,000 in total costs (direct plus indirect).
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI): Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youthhttps://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-026.html05/08/2024 expiration date05/04/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborTreating injured and traumatized children and efforts to implement preventive interventions have become increasingly challenging in the context of the current pandemic. Children are notably at greater risk of injury, morbidity and mortality due to the social isolation, economic stressors, and other challenges related to policies and practices designed to mitigate the spread of the coronavirus. Given the limitations of traditional contexts for identifying and reporting abuse due to these mitigation strategies, research on treatment and care in diverse (e.g. primary, emergency and acute care) settings is essential to identify effective ways of screening, diagnosing and assessing trends in abuse and abuse related injuries in this current context.
National Institutes of Health (NIH-NIDA)NIHNotice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirushttps://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-041.html03/31/2022 expiration date04/29/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for continued research on the impacts of SARS-CoV-2, the coronavirus that causes COVID-19. NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.Application budgets are generally limited to no more than $100,000 direct costs per year. Should the proposed research require a higher budget, the applicant should consult with the program official assigned to the parent award and include a strong justification for the larger budget in the supplement application. The proposed budget must reflect the actual needs of the proposed project.
National Institutes of Health (NIH)NIHEmergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing Among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-009.html07/07/202104/15/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborHigh rates and disparities of COVID-19 infection, morbidity, and mortality continue among underserved and vulnerable populations across the United States. The overarching goal of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative is to understand and ameliorate factors that have placed a disproportionate burden of the pandemic on underserved and/or vulnerable populations, specifically by implementing programs that expand the scope and reach of COVID-19 testing interventions to reduce these disparities. To address barriers to testing and vaccination, social, ethical, and behavioral research is urgently needed to inform related mitigation efforts. This Phase II RADx-UP Funding Opportunity Announcement (FOA) is designed to expand research to understand and address the social, ethical, and behavioral implications (SEBI) of COVID-19 testing interventions among underserved and vulnerable populations. Desirable studies for Phase II will move beyond descriptive health disparities research to focus on developing interventions and other actionable solutions in collaboration with community partners and stakeholders. The funding for this initiative is provided from the American Rescue Plan Act of 2021.Application budgets are limited to $400,000 per year in Direct Costs and need to reflect the actual needs of the proposed project. Up to 2 years.
National Institutes of Health (NIH)NIHEmergency Awards: Community-engaged COVID-19 Testing Interventions Among Underserved and Vulnerable Populations -- RADx-UP Phase II (U01 Clinical Trial Optional)https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-008.html07/07/202104/15/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis funding opportunity announcement (FOA) uses an emergency U01 mechanism to support Phase II of the Rapid Acceleration of Diagnostics – Underserved Populations (RADxSM-UP) initiative. These two-year Testing Research Projects will (1) expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and (2) address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines. The funding for this initiative is provided from the American Rescue Plan Act of 2021 .Application budgets in general are limited to $750,000 per year in Direct Costs and need to reflect the actual needs of the proposed project. Application budget requests over $750,000 in Direct Costs for any year must meet the additional criteria described in Section 1. Up to 2 years.
National Institutes of Health (NIH)NIHEmergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01)https://grants.nih.gov/grants/guide/pa-files/PAR-21-213.html11/08/202104/04/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this FOA is to advance research on the impact of SARS-CoV-2 and associated mitigation efforts on individual, family, and community behavior and on how subsequent economic disruption affects health-related outcomes, with close attention to underserved and vulnerable populations. To address these questions, this FOA aims to form a research consortium to access, extract, integrate, share, and analyze existing data from various sources with broad population coverage including underserved and vulnerable populations. Examples of existing data include public health data; personal digital data; economic, labor, and commerce data; electronic health records (EHRs); claims data; and ongoing health, demographic, and social surveys. This FOA solicits applications for individual population research projects that will be linked to a Social, Behavioral, and Economic Research on COVID-19 Consortium Coordination Center (SBECCC) to foster collaboration and synergies across consortium member projects.Application budgets are limited to less than $500,000 in direct costs in any year. All requested costs need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum project period is 5 years.
National Science Foundation (NSF)Non-NIH FederalTrans-Atlantic Platform Recovery, Renewal, and Resilience in a Post-Pandemic World (T-AP RRR)https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=50590907/12/202104/06/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe Trans-Atlantic Platform Recovery, Renewal, and Resilience in a Post-Pandemic World (T-AP RRR) opportunity supports international, collaborative research projects that address key gaps in our understanding of the complex societal effects of COVID-19.  Specifically, T-AP RRR supports research that addresses one or more of the following challenges:  reducing inequalities and vulnerabilities; building a more resilient, inclusive, and sustainable society; fostering democratic governance and participation; advancing responsible and inclusive digital innovation; and/or ensuring effective and accurate communication and media.
National Institutes of Health (NIH-NIMH, NICHD)NIHNotice of Special Interest (NOSI): COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Childrenhttps://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-225.html09/08/2022 expiration date04/06/2021Behavior and Psychology; Community and Social Services; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIMH is issuing this Notice of Special Interest (NOSI) to highlight interest in research to understand the mental health impact of the Coronavirus Disease 2019 (COVID-19) pandemic on school-aged children, specifically ages 3 - 12. Particularly, we are interested in the potential impact of primary instruction settings disruptions (e.g., pre-school, elementary school) on the mental health, cognitive, social, and emotional development of children. Empirical data would aid in balancing health risks for various public health mitigation strategies affecting children in the current pandemic as well as inform how to both be prepared and respond to future public health emergencies, including pandemics and disaster scenarios.
National Institutes of Health (NIH-NIGMS)NIHNotice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2https://grants.nih.gov/grants/guide/notice-files/NOT-GM-21-019.html12/16/2021 expiration date03/04/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIGMS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for modeling research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19).
National Institutes of Health (NIH-NIA)NIHNotice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegenerationhttps://grants.nih.gov/grants/guide/notice-files/NOT-AG-21-016.html05/08/2023 expiration date03/04/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Notice of Special Interest (NOSI) is to inform applicants to the National Institute on Aging (NIA) of NIA’s interest in basic and clinical mechanistic research on neurological and neurocognitive sequelae originating from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and Coronavirus Disease 2019 (COVID-19) in aging and age-related neurodegeneration.
Coalition for Epidemic Preparedness Innovations (CEPI)Academic Research InstituteOpen Calls for Proposals - COVID-19https://cepi.net/get_involved/cfps/02/17/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and Labor
National Institutes of Health (NIH-NIAID, NIMH)NIHNotice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Researchhttps://grants.nih.gov/grants/guide/notice-files/NOT-AI-21-011.html05/08/2024 expiration date02/16/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis Notice of Special Interest (NOSI) is to support projects that use data, alone or in combination, to address scientific questions and knowledge gaps in basic or clinical research in immune-mediated and infectious diseases.
National Institutes of Health (NIH-NIDA)NIHNotice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-017.html09/08/2024 expiration date02/10/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIDA is interested in receiving research applications focusing on individuals with HIV who smoke or vape marijuana, tobacco, cocaine and/or methamphetamine to determine the long-term effects of their use among individuals with HIV and COVID-19.
National Institutes of Health (NIH-NIDA)NIHNotice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disordershttps://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-018.html09/08/2024 expiration date02/10/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIDA is interested in receiving research applications focusing on studying the long-term neurocognitive consequences of the COVID-19/HIV/SUDs syndemic.
National Institutes of Health (NIH-NIDCR)NIHNotice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)https://grants.nih.gov/grants/guide/notice-files/NOT-DE-21-001.html05/08/2023 expiration date02/02/2021Epidemiology / Public Health; Life SciencesThe National Institute of Dental and Craniofacial Research (NIDCR) is issuing this Notice of Special Interest (NOSI) to encourage research studies focused on the physiological involvement of oral cavity and oral manifestations related to SARS-CoV-2 and/or Coronavirus Disease 2019 (COVID-19).
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparitieshttps://grants.nih.gov/grants/guide/notice-files/NOT-MD-21-008.html01/08/2022 expiration date01/07/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThis Notice of Special Interest (NOSI) highlights the need for research strategies and interventions to address vaccine hesitancy, uptake, and implementation among populations who experience health disparities in the US.* Research is needed to understand and address misinformation, distrust, and hesitancy regarding vaccines (e.g., SARS-CoV-2, pneumococcal, influenza, hepatitis B, human papilloma virus (HPV), and herpes zoster) among adults in the United States and territories, especially in populations at increased risk for morbidity and mortality due to long-standing systemic health and social inequities and chronic medical conditions. The purpose of this NOSI is to solicit community-engaged research to: 1) evaluate intervention strategies (e.g., expand reach, access) to facilitate vaccination uptake in clinical and community contexts; and 2) address the barriers to increasing reach, access, and uptake of vaccinations among health disparity populations at high risk and likely to experience vaccine hesitancy.
National Insitutes of Health (NIH-NIMH)NIHNotice of Special Interest (NOSI): Administrative Supplements for COVID-19 Impacted NIMH Researchhttps://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-120.html06/02/2023 expiration date01/07/2021Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Notice is to outline priorities for providing supplemental funding to investigators and institutions with active National Institute of Mental Health (NIMH) awards that have been significantly impacted by the COVID-19 pandemic.
National Institutes of Health (NIH-NICHD)NIHNotice of Special Interest (NOSI): Research on Rehabilitation Needs Associated with the COVID-19 Pandemichttps://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-031.html05/08/2023 expiration date11/16/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe purpose of this Notice of Special Interest is to encourage applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation: 1) Encourage research to address the rehabilitation needs of survivors of COVID-19; 2) Understand the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions; and 3) Understand the social, behavioral, economic, and health impact of the COVID-19 pandemic and the associated mitigation actions on people with physical disabilities
National Institutes of Health (NIH-NIDCD)NIHNotice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disordershttps://grants.nih.gov/grants/guide/notice-files/NOT-DC-20-008.html09/08/2022 expiration date11/16/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborCoronavirus Disease 2019 (COVID-19) is a recently emerged human disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). There is a paucity of data on the impact of SARS-CoV-2 on the sensory and communicative functions within the scientific mission areas of NIDCD. NIDCD invites applications for research on COVID-19 in relation to NIDCD's scientific programs of hearing, balance, taste, smell, voice, speech and language (HBTSVSL). Given the early stage of COVID-19 research, it is critical that there is a strong premise for research proposals submitted in response to this NOSI. When appropriate, NIDCD encourages multi-disciplinary approaches to move the research beyond in vitro and animal models.
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Projecthttps://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-129.html07/13/2021 expiration date11/13/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborNIH is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in individuals with Down syndrome in conjunction with the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project.
National Institutes of Health (NIH-NIDA)NIHNotice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infectionhttps://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-011.html09/08/2024 expiration date11/09/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThe purpose of this notice is to communicate NIDA’s interest in supporting research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection.
National Institutes of Health (NIH-NHLBI)NIHNotice of Special Interest (NOSI): The Influence of Host Resiliance on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-814.html07/06/2024 expiration date11/09/2020Epidemiology / Public Health; Life SciencesThe purpose of this Notice of Special Interest (NOSI) is to inform potential applicants of the special interest of NHLBI in research to understand host resilience as a critical determinant of outcomes in acute respiratory distress syndrome (ARDS) /acute lung injury (ALI).
National Institutes of Health (NIH-NICHD)NIHNotice of Special Interest (NOSI): Emerging Viral Infections and Their Impact on the Male and Female Reproductive Tracthttps://grants.nih.gov/grants/guide/notice-files/NOT-HD-20-021.html07/16/2023 expiration date11/09/2020Epidemiology / Public Health; Life SciencesThe purpose of this Notice is to invite applications proposing cutting-edge research on emerging viral infections that are thought to primarily impact non-reproductive sites, at least at initial presentation, but may also affect the male and/or female reproductive tract. The recent global outbreak of the novel coronavirus, SARS-CoV-2, is not an anomaly and will most likely not be the last virus occurrence. Today, infectious diseases are emerging and reemerging more quickly than ever before. In the last four-five years alone, two viral infections, one caused by the Zika virus (ZIKV) and the other caused by a SARS-CoV-2 (Covid19), have spread world-wide, resulting in death, severe disease with yet, unknown, long-term morbidities., or severe birth defects to the new-born. Both ZIKV and SARS-CoV-2 infections may affect male and/or female reproductive systems in addition to other non-reproductive sites. Therefore, it becomes essential to investigate possible effects of emerging viruses on reproductive tissues and cells to better understand potential impacts on fertility that may be sex specific.
BARDANon-NIH FederalBroad Agency Accouncement (BAA) Supporting Research for the US Department of Health and Human Services Under Contracts, Other Transaction Agreements, and Technology Investment Agreements for the Treatment and Protection from COVID-19https://beta.sam.gov/opp/d3b19cfbad31430dab3880812ce2abf3/view?index=opp&preference_id=300d6387-f360-4099-8eee-52a1659952c7&page=11&sort=-modifiedDate&keywords=%22broad%20agency%20announcement%22%20%22BAA%22&date_filter_index=0&inactive_filter_values=fals08/01/2022 expiration date08/10/2020Epidemiology & Public Health; Life Sciences
Economic Development Administration (EDA)Non-NIH FederalFunding Opportunitieshttps://eda.gov/funding-opportunities/08/04/2020Community & Social Services; Policy, Economics & Labor
CiscoIndustry SponsorRequests for Proposalshttps://research.cisco.com/research-grants07/16/2020Data Science, AI & Computing; Engineering; Epidemiology & Public HealthFor more information about this opportunity, please contact Scott Stevenson (swstevenson@ucdavis.edu), Associate Director of Corporate Engagement
National Institutes of Health (NIH - NIAID)NIHLimited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10)https://grants.nih.gov/grants/guide/pa-files/PAR-20-256.html07/08/2021 expiration date07/15/2020Community & Social Services; Epidemiology & Public Health; Life SciencesThe purpose of this public health emergency funding opportunity is to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19. This program will ensure that adequate protective equipment is available to directly assist in safely carrying out the clinical activities and direct interactions with the patients participating in the trial. Eligibility is limited to recipients conducting COVID-related clinical research and clinical studies supported by NIAID’s emergency appropriation provided by “The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020” and “The Coronavirus Aid, Relief and Economic Security (CARES) Act”.It is expected that applicants will employ the most economical approaches, including securing academic discounts, to formulate a cost-effective budget while meeting users' needs.
Open Road AllianceFoundationCharitable Grantshttps://openroadalliance.org/covid-19/06/26/2020Community & Social Services; Data Science, AI & Computing; Engineering; Epidemiology & Public Health; Humanities; Life Sciences; Policy, Economics & LaborFor more information about this opportunity, please contact Traci Galbaugh (tlgalbaugh@ucdavis.edu), Senior Director of Foundation Engagement
Draper Richards Kaplan FoundationFoundationCOVID-19 Urgent Response Initiativehttps://drive.google.com/file/d/1Dcj2zuFKE72caEBYz5ADOLDWeci802cD/view05/18/2020Behavior & Psychology; Community & Social Services; Data Science, AI & Computing; Engineering; Humanities; Policy, Economics & Labor; InstructionDRK is ready to find, fund, and support the people and ideas that are tackling the most acute and time-critical social problems caused by the Covid-19 pandemic right now. We want to help jumpstart projects that can realistically deploy within 30 days. We are best positioned to help work on the social problems caused by the pandemic versus direct mitigation via medical and scientific efforts. We will filter potential investments through the lens of urgency: Can this make large impact at scale? Can it be deployed quickly? And can DRK be catalytic in making that happen?Anticipated Range $50K-$100K
CETF and Rockefeller Philanthropy AdvisorsFoundationCOVID-19 Early Treatment Fund (CETF)http://www.treatearly.org/apply-for-funding05/12/2020Epidemiology & Public Health; Life SciencesFor more information about this opportunity, please contact Charlie Lemcke (cwlemcke@ucdavis.edu), Assistant Director of Corporate EngagementUp to $1M
Economic Development Administration (EDA)Non-NIH FederalEDA CARES Act Recovery Assistancehttps://www.eda.gov/coronavirus/05/12/2020Community & Social Services; Policy, Economics & LaborThe Coronavirus Aid, Relief, and Economic Security (CARES) Act provides the EDA with $1.5 billion for economic development assistance programs to help communities prevent, prepare for, and respond to coronavirus. EDA CARES Act Recovery Assistance provides a wide-range of financial assistance to communities and regions as they respond to and recover from the impacts of the pandemic. This includes: 1) Planning and Technical Assistance, 2) Construction of Infrastructure and Other Economic Development Projects, 3) Innovation Grants, and 4) Capitalization and Recapitalization of Revolving Loan Funds. Check that the proposed project fits the scope with the EDA regional office; applications reviewed on rolling basis.Typically up to $1,000,000
National Institutes of Health (NIBIB)NIHRapid Acceleration of Diagnostics (RADx)https://www.poctrn.org/radx04/28/2020 begins rolling deadline04/29/2020Epidemiology / Public Health; Life SciencesThe National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches.Varies by Phase
National Institutes of Health (NIH)NIHAll open COVID-19 calls and Notices of Special Interest (NOSIs) from the Instituteshttps://grants.nih.gov/policy/natural-disasters/corona-virus.htm04/24/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and Labor; Education and TrainingThis page on the NIH website contains a table of all open COVID-19 calls and Notices of Special Interest (NOSIs) from the Institutes, in addition to other useful information. At this time there are too many NIH NOSIs to add to this table.Various
National Institutes of Health (NIH)NIHEmergency Competitive Revision to Existing NIH Awardshttps://grants.nih.gov/grants/guide/pa-files/PA-20-135.html04/10/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster. Applications for Emergency Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award. Only applications submitted in response to an Emergency Notice of Special Interest (NOSI) published by an IC will be allowed to apply to this FOA.
GoogleIndustry SponsorGoogle Cloud research creditshttps://edu.google.com/programs/credits/research/?modal_active=none04/09/2020Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Amy Skehan (arskehan@ucdavis.edu), Assistant Vice Chancellor of Foundation and Corporate Engagement
BARDANon-NIH FederalCoronaWatch/TechWatch Medical Countermeasureshttps://www.medicalcountermeasures.gov/request-barda-techwatch-meeting/04/07/2020Engineering; Life SciencesTo enable a rapid-response to the COVID-19 outbreak, BARDA has repurposed its existing TechWatch program to focus on COVID-19 medical countermeasures. These CoronaWatch submissions and meetings aim to give innovators and innovative companies a government-wide platform to discuss their ideas with U.S. government experts, and seek partnership opportunities with a wide range of potential federal partners. BARDA is particularly interested in products and technologies that have progressed into or beyond non-clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. Information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak are sought.
California Institute for Regenerative Medicine (CIRM)State of CaliforniaCIRM Rapid Research Fundshttps://www.cirm.ca.gov/about-cirm/newsroom/press-releases/03272020/stem-cell-agency-board-approves-5-million-emergency04/07/2020Epidemiology / Public Health; Life SciencesCIRM is issuing this special announcement to support promising discovery, preclinical and clinical trial stage projects that could quickly advance treatments to COVID-19 patients in need.Varies by Project Stage
Allen Institute for AIPublic-Private PartnershipCOVID-19 Open Research Dataset Challengehttps://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge04/02/2020Data Science, AI, ComputingFor more information about this opportunity, please contact Robyn Ireland (rmbireland@ucdavis.edu), Assistant Director of Corporate Engagement$1,000 per task
DoE OSTP IBMPublic-Private PartnershipCOVID-19 High Performance Computing Consortiumhttps://covid19-hpc-consortium.org/04/02/2020Behavior and Psychology; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life SciencesThe COVID-19 High Performance Computing Consortium helps aggregate computing capabilities from the world's most powerful and advanced computers to help COVID-19 researchers execute complex computational research programs to help fight the virus.  Researchers seeking to access the Consortium’s resources should submit a simple project proposal that will be reviewed for potential impact, computational feasibility, overall resource requirements and timeline.
Gates Foundation, Wellcome Trust, Mastercard, & CZIFoundationCOVID-19 Therapeutics Acceleratorhttps://www.therapeuticsaccelerator.org/04/02/2020Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Traci Galbaugh (tlgalbaugh@ucdavis.edu), Senior Director of Foundation Engagement
Ginkgo BioworksIndustry SponsorFree Access to Ginkgo Platformhttps://www.ginkgobioworks.com/2020/03/17/ginkgo-commits-25m-of-free-access-to-our-platform-for-partner-covid-19-projects/04/02/2020Data Science, AI, Computing; Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Jamie Shattuck (jkshattuck@ucdavis.edu), Senior Director of Corporate Engagement
NIH-NIAID & NIANIHInvestigator Initiated Extended Clinical Trial (R01)https://grants.nih.gov/grants/guide/pa-files/PAR-20-139.html09/13/2021 next deadline05/27/2021Epidemiology / Public Health; Life SciencesThis Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of one of the participating ICs. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.